| Stage | MDLZ | % of rev | FLO | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $10.0B | 100.00% | $1.2B | 100.00% | MDLZ ×8.36 |
| Gross profit | $3.9B | 39.37% | $578M | 48.45% | FLO +9.1pp |
| Operating income | $1.8B | 17.64% | $68M | 5.71% | MDLZ +11.9pp |
| Pre-tax income | $1.7B | 17.27% | $54M | 4.55% | MDLZ +12.7pp |
| Net income | $1.3B | 13.12% | $41M | 3.41% | MDLZ +9.7pp |
| Stage | MDLZ | FLO | Gap · A − B |
|---|---|---|---|
| Revenue | $10.0B100.00% | $1.2B100.00% | MDLZ ×8.36 |
| Gross profit | 39.37%$3.9B | 48.45%$578M | FLO +9.1pp |
| Operating income | 17.64%$1.8B | 5.71%$68M | MDLZ +11.9pp |
| Pre-tax income | 17.27%$1.7B | 4.55%$54M | MDLZ +12.7pp |
| Net income |
| 13.12%$1.3B |
| 3.41%$41M |
| MDLZ +9.7pp |